Skip to main content

Advertisement

SpringerLink
Log in

Lymphoid tissue inducer cells in cancer: a potential therapeutic target

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Tumor cells are dynamic in nature; these cells first acquire immune surveillance and then escape from the immune system. Hence, progressed cancer cells distribute and metastasize to other organs via blood vessels as well as from the lymphatic system. Prognosis and treatment of metastatic cancer patients remain a major challenge nowadays. Till now, lots of target -based and immune checkpoint blocker therapies are used to treat disease patients. But these therapies fail to control the dissemination and metastasis of cancer. Before designing a treatment regimen for metastatic patients, understanding the mechanism of tumor cells spreading within lymph vessels remain undetermined. Construction of lymphoid structures since embryonic to adult stage are depend upon LTi. Foundation of lymph node, payer patches and TLO is initiated and regulated through these cells in any part of the body. During tumor growth, newly developed lymph node contained MDSCs and Treg cells which inhibit the immune response and promote tumor invasion and metastasis. LTi reconstituted lymph node can be used for both early and high risk detection of cancers. High and low risk of tumor growth and invasion depend upon the location and composition of immune cells within lymph nodes. However, LTi are not reported as predictive marker in cancer till date. Recent reports in cancer indicate that LTi cells are engaged in the spreading of tumor cells into a lymphatic vessel. Through this review we are trying to brief the development and role of the LTi in immune system during homeostasis and cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated and analysed during the current study are not publicly available but are available from the corresponding author upon reasonable request.

References

  1. Vivier E et al (2018) Innate lymphoid cells: 10 years on. Cell 174(5):1054–1066

    Article  CAS  PubMed  Google Scholar 

  2. Mebius RE (2003) Organogenesis of lymphoid tissues. Nat Rev Immunol 3(4):292–303

    Article  CAS  PubMed  Google Scholar 

  3. Strober W (2010) The LTi cell, an immunologic chameleon. Immunity 33(5):650–652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. van de Pavert SA (2021) Lymphoid Tissue inducer (LTi) cell ontogeny and functioning in embryo and adult. Biomed J 44(2):123–132

    Article  PubMed  Google Scholar 

  5. Sawa S et al (2010) Lineage relationship analysis of RORγt+ innate lymphoid cells. Science (80-) 330(6004):665–669

    Article  CAS  Google Scholar 

  6. Ishizuka IE et al (2016) Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue–inducer cell lineage. Nat Immunol 17(3):269–276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A (2014) A committed precursor to innate lymphoid cells. Nature 508(7496):397–401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Constantinides MG et al (2015) PLZF expression maps the early stages of ILC1 lineage development. Proc Natl Acad Sci USA 112(16):5123–5128

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhong C et al (2020) Differential expression of the transcription factor GATA3 specifies lineage and functions of innate lymphoid cells. Immunity 52(1):83-95.e4

    Article  CAS  PubMed  Google Scholar 

  10. Zhu Q et al (2020) Developmental trajectory of prehematopoietic stem cell formation from endothelium. Blood 136(7):845–856

    Article  PubMed  PubMed Central  Google Scholar 

  11. Boos MD, Yokota Y, Eberl G, Kee BL (2007) Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 204(5):1119–1130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Possot C et al (2011) Notch signaling is necessary for adult, but not fetal, development of RORγt(+) innate lymphoid cells. Nat Immunol 12(10):949–958

    Article  CAS  PubMed  Google Scholar 

  13. Van De Pavert SA et al (2014) Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508(7494):123–127

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hoorweg K, Cupedo T (2008) Development of human lymph nodes and Peyer’s patches. Semin Immunol 20(3):164–170

    Article  CAS  PubMed  Google Scholar 

  15. Withers DR (2011) Lymphoid tissue inducer cells. Curr Biol 21(10):R381–R382

    Article  CAS  PubMed  Google Scholar 

  16. Lane PJL, Gaspal FMC, Kim MY (2005) Two sides of a cellular coin: CD4+CD3- cells regulate memory responses and lymph-node organization. Nat Rev Immunol 5(8):655–660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bekiaris V et al (2013) Human CD4 + CD3 − innate-like T cells provide a source of TNF and Lymphotoxin-αβ and are elevated in rheumatoid arthritis. J Immunol 191(9):4611–4618

    Article  CAS  PubMed  Google Scholar 

  18. Finke D, Acha-Orbea H, Mattis A, Lipp M, Kraehenbuhl JP (2002) CD4+CD3− cells induce Peyer’s patch development: role of α4β1 integrin activation by CXCR5. Immunity 17(3):363–373

    Article  CAS  PubMed  Google Scholar 

  19. Sécca C et al (2021) Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity. Proc Natl Acad Sci USA 118(23):e2101668118

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ruddle NH (2020) Basics of inducible lymphoid organs. Curr Top Microbiol Immunol 426:1–19

    CAS  PubMed  Google Scholar 

  21. Schropp V, Rohde J, Rovituso DM, Jabari S, Bharti R, Kuerten S (2019) Contribution of LTi and TH17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis. J Neuroinflamm. https://doi.org/10.1186/s12974-019-1500-x

    Article  Google Scholar 

  22. Peng V, Jaeger N, Colonna M (2022) Innate lymphoid cells and inflammatory bowel disease. Adv Exp Med Biol 1365:97–112

    Article  PubMed  Google Scholar 

  23. Marinkovic T et al (2006) Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest 116(10):2622–2632

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Berteloot L et al (2021) Alternative pathways for the development of lymphoid structures in humans. Proc Natl Acad Sci USA 118(29):2108082118

    Article  Google Scholar 

  25. Irshad S et al (2017) RORγt+ innate lymphoid cells promote lymph node metastasis of breast cancers. Cancer Res 77(5):1083–1096

    Article  CAS  PubMed  Google Scholar 

  26. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science (80-) 328(5979):749–752

    Article  CAS  Google Scholar 

  27. de la García-Hernández ML, Uribe-Uribe NO, Espinosa-González R, Kast WM, Khader SA, Rangel-Moreno J (2017) A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression. Front Immunol. https://doi.org/10.3389/fimmu.2017.00563

    Article  PubMed  PubMed Central  Google Scholar 

  28. Joshi NS et al (2015) Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses. Immunity 43(3):579–590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Horeweg N et al (2022) Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. Nat Commun 13(1):1373

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cabrita R et al (2020) Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577(7791):561–565

    Article  CAS  PubMed  Google Scholar 

  31. Kroeger DR, Milne K, Nelson BH (2016) Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer. Clin Cancer Res 22(12):3005–3015

    Article  CAS  PubMed  Google Scholar 

  32. Lauss M, Donia M, Svane IM, Jönsson G (2022) B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? Clin Cancer Res 28(9):1751

    Article  CAS  PubMed  Google Scholar 

  33. Rodriguez AB, Engelhard VH (2020) Insights into tumor-associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy: tertiary lymphoid structures in cancer. Cancer Immunol Res 8(11):1338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Santarpia M et al (2023) Turning tertiary lymphoid structures (TLS) into hot spots: values of TLS in gastrointestinal tumors. Cancers 15(2):367

    Article  Google Scholar 

  35. Furtado GC et al (2007) Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc Natl Acad Sci USA 104(12):5026–5031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Hindley JP et al (2012) T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res 72(21):5473–5482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Colbeck EJ et al (2017) Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction. Cancer Immunol Res 5(11):1005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Withers DR et al (2012) Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J Immunol 189(5):2094–2098

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

There is no funding support from any goverment and private agencies.

Author information

Authors and Affiliations

  1. Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India

    Ashu Singh & Alpana Sharma

Authors
  1. Ashu Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alpana Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AS and AS designed and conceptualized the manuscript. All the authors review the manuscript.

Corresponding author

Correspondence to Alpana Sharma.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, A., Sharma, A. Lymphoid tissue inducer cells in cancer: a potential therapeutic target. Mol Cell Biochem 478, 2789–2794 (2023). https://doi.org/10.1007/s11010-023-04699-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-023-04699-y

Keywords

Search

Navigation